Clinical trial
A Study of Fluconazole in the Prevention of Fungal Infections in HIV-Infected…
NCT00002325 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00002325 |
|---|---|
| Title | A Study of Fluconazole in the Prevention of Fungal Infections in HIV-Infected Patients Living in Areas Where Fungal Infections Are Common |
| Official title | A Double-Blind, Placebo-Controlled Study of Fluconazole in the Prevention of Active Coccidioidomycosis and Other Systemic Fungal Infections in HIV-Infected Patients Living in the Coccidioidal Endemic Area |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Mycoses, HIV Infections, Coccidioidomycosis |
| Intervention type | Drug |
| Interventions | Fluconazole |
| First posted | Aug 31, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: